Año: 2020
Journal Impact Factor (JIF): 5.2510
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
PHARMACOLOGY & PHARMACY | SCIE | 54/276 | Q1 | T1 | D2 |
NEUROSCIENCES | SCIE | 72/273 | Q2 | T1 | D3 |
Año: 2020
Journal Citation Indicator (JCI): 1,280
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
NEUROSCIENCES | 59/293 | Q1 | T1 | D2 | 80,03 |
PHARMACOLOGY & PHARMACY | 43/357 | Q1 | T1 | D2 | 88,10 |
Año:
2020
CiteScore:
9,000
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cellular and Molecular Neuroscience | 16/88 | Q1 | T1 | D2 |
Pharmacology | 33/297 | Q1 | T1 | D2 |
SJR año:
2020
Factor de Impacto:
1,760
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmacology | 33/331 | Q1 | T1 | D1 |
Cellular and Molecular Neuroscience | 24/95 | Q2 | T1 | D3 |
Agencia | Código de Proyecto |
---|---|
- | UMA18-FEDERJA-100 |
Hjarnfonden, Sweden | F02018-0286; F02019-0296 |
Karolinska Institutet Forskningsstiftelser, Sweden | - |
Parkinson Fonden, Sweden | - |
Proyecto Puente, Spain | - |
Swedish Medical Research Council, Sweden | 62X-00715-50-3 |
# | Autor | Afiliación |
---|---|---|
1 | Narváez, M | Karolinska Institute Department of Neuroscience; University of Malaga Faculty of Medicine (Sweden) |
2 | Andrade-Talavera, Y | Karolinska Institute Department of Neurobiology Care Sciences and Society (Sweden) |
3 | Valladolid-Acebes, I | Karolinska University Hospital (Sweden) |
4 | Fredriksson, M | Karolinska Institute Department of Neuroscience (Sweden) |
5 | Siegele, P | Karolinska Institute Department of Neuroscience (Sweden) |
6 | Hernandez-Sosa, A | Karolinska Institute Department of Neuroscience (Sweden) |
7 | Fisahn, A | Karolinska Institute Department of Neurobiology Care Sciences and Society (Sweden) |
8 | Fuxe, K | Karolinska Institute Department of Neuroscience (Sweden) |
9 | University of Urbino; Karolinska Institute Department of Neuroscience; Observ Cubano Neurociencias (Sweden) |